Duquesne
NUVB · Medicine & biotech

Nuvation Bio

Makes cancer drugs, including the lung cancer pill Ibtrozi.
No change
Duquesne owns 4.5 million shares of Nuvation Bio, worth about $26 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
4,539,800
Jun 30
4,539,800

The numbers

Shares they own
4,539,800
Value on Jun 30, 2026
$25,786,000
about $26 million
Share of their money
0.6%
less than $1 of every $100 · 31st of 85
Price per share on Jun 30
$5.68
Kind
Shares
More about Nuvation Bio
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works